A safe and effective mucosal RSV vaccine in mice consisting of RSV phosphoprotein and flagellin variant-Reference-Cited by-同舟云学术

A safe and effective mucosal RSV vaccine in mice consisting of RSV phosphoprotein and flagellin variant

Published:2021-07 Issue:3 Volume:36 Page:109401
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Zhao Bali,Yang Jingyi,He Bing,Li Xian,Yan Hu,Liu Shuning,Yang Yi,Zhou Dihan,Liu Bowen,Fan Xuxu,Zhong Maohua,Zhang Ejuan,Zhang Fan,Zhang Yue,Chen Yao-Qing,Jiang Shibo,Yan Huimin

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference73 articles.

1. Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines;Asahi;J. Immunol.,2002

2. Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans;Bacher;Cell,2019

3. Flagellin-PAc Fusion Protein Inhibits Progression of Established Caries;Bao;J. Dent. Res.,2015

4. Recovery of cytopathogenic agent from chimpanzees with coryza;Blount;Proc. Soc. Exp. Biol. Med.,1956

5. The immune modulator FTY720 targets sphingosine 1-phosphate receptors;Brinkmann;J. Biol. Chem.,2002

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mucosal delivery of a prefusogenic-F, glycoprotein, and matrix proteins-based virus-like particle respiratory syncytial virus vaccine induces protective immunity as evidenced by challenge studies in mice;Virology;2024-10

2. Chiral Intranasal Nanovaccines as Antivirals for Respiratory Syncytial Virus;Advanced Materials;2024-09-02

3. Cold-adapted influenza vaccine carrying three repeats of a respiratory syncytial virus (RSV) fusion glycoprotein epitope site protects BALB/c mice and cotton rats against RSV infection;Antiviral Research;2024-09

4. Cold‐adapted influenza‐vectored RSV vaccine protects BALB/c mice and cotton rats from RSV challenge;Journal of Medical Virology;2024-07

5. Nasal vaccination of triple-RBD scaffold protein with flagellin elicits long-term protection against SARS-CoV-2 variants including JN.1;Signal Transduction and Targeted Therapy;2024-04-27